There is no robust clinical evidence that B12 injections enhance energy, alertness, or performance in individuals whose B12 levels are already adequate
In formal pharmacokinetic studies in rats following intravenous administration, BPC-157 has a mean elimination half-life of approximately 15.2 minutes, with the peptide becoming undetectable within 4 hours
It consists of the first 29 amino acids of the naturally occurring GHRH molecule, the shortest sequence that retains full biological activity
The initial B12 IV drip can take up to 30 minutes and can be administered weekly
Simultaneous administration of potassium-sparing diuretics may be associated with increased serum potassium concentration
A spokesperson for the NHS told GB News that they would not comment on individual cases but "if theres severe clinical evidence that supports the notion of patient harm, there are alternatives, and as such, if patients do have notable issues, they could receive the injection", adding that NICE can speak directly to the "efficacy of treatments"